3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Dermatologic
1
Conditions
Melanoma
33
Carcinoma, Non-Small-Cell Lung
6
Uveal Melanoma
5
Skin Neoplasms
5
Neoplasms
5
Lymphoma, T-Cell, Cutaneous
4
Kidney Neoplasms
4
Sarcoma
3
Prostatic Neoplasms
3
Mycosis Fungoides
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Urinary Bladder Neoplasms
2
Sezary Syndrome
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Lung Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Basal Cell
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urticaria Pigmentosa
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Pruritus
1
Pancreatic Neoplasms
1
Interventions
pembrolizumab
2
Imatinib Mesylate
2
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Quality of Life
1
Protons
1
Patient Reported Outcome Measures
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunotherapy
1
GSK-3326595
1
Drug Therapy
1
Docetaxel
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Adenoid Cystic
×
Blood Specimen Collection
×
Dermatologic
×
Clear all
NCT01046487
2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1
Completed
26 enrolled